BlackRock’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-4,296,333
Closed -$26.2M 5835
2021
Q3
$26.2M Buy
4,296,333
+2,278
+0.1% +$13.9K ﹤0.01% 3053
2021
Q2
$35.3M Sell
4,294,055
-222,061
-5% -$1.83M ﹤0.01% 2886
2021
Q1
$40.4M Buy
4,516,116
+176,792
+4% +$1.58M ﹤0.01% 2720
2020
Q4
$50.1M Buy
4,339,324
+216,183
+5% +$2.49M ﹤0.01% 2424
2020
Q3
$42.9M Buy
4,123,141
+691,089
+20% +$7.19M ﹤0.01% 2337
2020
Q2
$45.1M Buy
3,432,052
+461,242
+16% +$6.07M ﹤0.01% 2285
2020
Q1
$23.4M Sell
2,970,810
-93,842
-3% -$739K ﹤0.01% 2486
2019
Q4
$63.4M Buy
3,064,652
+55,653
+2% +$1.15M ﹤0.01% 2203
2019
Q3
$41.2M Buy
3,008,999
+230,135
+8% +$3.15M ﹤0.01% 2398
2019
Q2
$34.2M Sell
2,778,864
-11,573
-0.4% -$142K ﹤0.01% 2523
2019
Q1
$34.8M Sell
2,790,437
-67,594
-2% -$844K ﹤0.01% 2473
2018
Q4
$32.4M Sell
2,858,031
-10,957
-0.4% -$124K ﹤0.01% 2460
2018
Q3
$53.7M Buy
2,868,988
+39,511
+1% +$739K ﹤0.01% 2323
2018
Q2
$73.1M Buy
2,829,477
+217,510
+8% +$5.62M ﹤0.01% 2120
2018
Q1
$58.5M Sell
2,611,967
-39,019
-1% -$874K ﹤0.01% 2174
2017
Q4
$66.4M Buy
2,650,986
+392,055
+17% +$9.82M ﹤0.01% 2092
2017
Q3
$54.6M Buy
2,258,931
+60,846
+3% +$1.47M ﹤0.01% 2219
2017
Q2
$44.4M Buy
2,198,085
+85,426
+4% +$1.73M ﹤0.01% 2314
2017
Q1
$56.9M Buy
2,112,659
+2,110,357
+91,675% +$56.8M ﹤0.01% 2128
2016
Q4
$44K Buy
2,302
+363
+19% +$6.94K ﹤0.01% 2936
2016
Q3
$38K Sell
1,939
-79
-4% -$1.55K ﹤0.01% 3033
2016
Q2
$31K Buy
2,018
+853
+73% +$13.1K ﹤0.01% 3091
2016
Q1
$11K Buy
1,165
+654
+128% +$6.18K ﹤0.01% 3079
2015
Q4
$10K Buy
511
+353
+223% +$6.91K ﹤0.01% 2872
2015
Q3
$2K Hold
158
﹤0.01% 3145
2015
Q2
$3K Hold
158
﹤0.01% 3150
2015
Q1
$4K Buy
+158
New +$4K ﹤0.01% 3045